Microbix Biosystems Inc.
MBXBF · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $13 | $25 | $17 | $19 |
| % Growth | -47.5% | 53.8% | -13.4% | – |
| Cost of Goods Sold | $6 | $10 | $9 | $8 |
| Gross Profit | $7 | $15 | $7 | $11 |
| % Margin | 53% | 60.6% | 45.3% | 58.3% |
| R&D Expenses | $2 | $2 | $2 | $2 |
| G&A Expenses | $0 | $9 | $7 | $5 |
| SG&A Expenses | $7 | $9 | $8 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8 | $11 | $10 | $9 |
| Operating Income | -$1 | $4 | -$3 | $3 |
| % Margin | -8.5% | 15.4% | -16.6% | 14.1% |
| Other Income/Exp. Net | -$1 | -$0 | $3 | -$1 |
| Pre-Tax Income | -$2 | $4 | -$0 | $2 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$2 | $4 | -$0 | $2 |
| % Margin | -12.1% | 13.9% | -0.2% | 9.4% |
| EPS | -0.012 | 0.026 | -0 | 0.013 |
| % Growth | -145% | 8,700% | -102.3% | – |
| EPS Diluted | -0.012 | 0.026 | -0 | 0.013 |
| Weighted Avg Shares Out | 139 | 137 | 138 | 135 |
| Weighted Avg Shares Out Dil | 139 | 137 | 138 | 142 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $2 | $1 | $1 |
| EBITDA | $0 | $6 | $2 | $3 |
| % Margin | 2.3% | 24.4% | 11.9% | 17.4% |